• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Li Bin

Report says US hospitals still marking up drug prices by 500%. This must stop, and China’s got the right answer.

Steve Walker    October 24, 2017 May 7, 2018    No Comments on Report says US hospitals still marking up drug prices by 500%. This must stop, and China’s got the right answer.

The News: Hospitals markup medicine prices, on average, nearly 500%, according to a new analysis from the Moran Company that was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). The… Read more »

Pharmaceuticals    340B Drug Discount Program, Affordable Care Act, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Community Health Systems Inc., Fang Laiying, Ge Bai, Gerard Anderson, HCA Healthcare Inc., Health Affairs, HealthEconomics.Com, Li Bin, Medicare Payment Advisory Commission, Moran Company, North Okaloosa Medical Center, Obamacare, Pharmaceutical Research and Manufacturers of America, PhRMA, Xinhua

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
  • IPOs are back in business; well, unless and until there’s another government shutdown.
  • And now for something completely different in biotech: Lab-grown, “clean” meat. If Bill Gates and Warren Buffett like the idea...well?...
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress